Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Leukemia

  Free Subscription


Articles published in Ann Oncol

Retrieve available abstracts of 17 articles:
HTML format



Single Articles


    May 2021
  1. DONNETTE M, Ciccolini J, Pissier C, Costello R, et al
    High incidence of CDA deficiency in patients with hematological malignancies: perspectives and therapeutic implications.
    Ann Oncol. 2021;32:684-686.
    PubMed    


    January 2021
  2. CARIOLI G, Malvezzi M, Bertuccio P, Boffetta P, et al
    European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer.
    Ann Oncol. 2021 Jan 21. pii: S0923-7534(21)00014.
    PubMed     Abstract available


  3. EICHHORST B, Robak T, Montserrat E, Ghia P, et al
    Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Ann Oncol. 2021;32:23-33.
    PubMed    


    June 2020
  4. HEUSER M, Ofran Y, Boissel N, Brunet Mauri S, et al
    Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Ann Oncol. 2020;31:697-712.
    PubMed    


    April 2019
  5. RUPPERT AS, Yin J, Davidian M, Tsiatis AA, et al
    Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia.
    Ann Oncol. 2019;30:542-550.
    PubMed     Abstract available


    February 2019
  6. RUPPERT AS, Yin J, Davidian M, Tsiatis AA, et al
    Application of a Sequential Multiple Assignment Randomized Trial (SMART) Design in Older Patients with Chronic Lymphocytic Leukemia.
    Ann Oncol. 2019 Feb 25. pii: 5364262. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  7. BUSKE C, Hutchings M, Ladetto M, Goede V, et al
    ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma.
    Ann Oncol. 2018;29:544-562.
    PubMed     Abstract available


    January 2018
  8. ROLLIG C, Kramer M, Gabrecht M, Hanel M, et al
    Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicine for acute myeloid leukemia in elderly patients.
    Ann Oncol. 2018 Jan 30. pii: 4829566. doi: 10.1093.
    PubMed     Abstract available


  9. KHOURY HJ, Gambacorti-Passerini C, Brummendorf TH
    Practical Management of Toxicities Associated With Bosutinib in Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia.
    Ann Oncol. 2018 Jan 27. pii: 4827630. doi: 10.1093.
    PubMed     Abstract available


  10. RAPONI S, Del Giudice I, Marinelli M, Wang J, et al
    Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients.
    Ann Oncol. 2018 Jan 22. pii: 4819111. doi: 10.1093.
    PubMed     Abstract available


    September 2017
  11. HEIDRICH K, Thiede C, Schafer-Eckart K, Schmitz N, et al
    Allogeneic Hematopoietic Cell Transplantation in Intermediate Risk Acute Myeloid Leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA Mutations.
    Ann Oncol. 2017 Sep 1. doi: 10.1093.
    PubMed     Abstract available


    May 2017
  12. MATO AR, Hill BT, Lamanna N, Barr PM, et al
    Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.
    Ann Oncol. 2017;28:1050-1056.
    PubMed     Abstract available


    April 2017
  13. JAIN P, Aoki E, Keating M, Wierda WG, et al
    Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).
    Ann Oncol. 2017 Apr 4. doi: 10.1093.
    PubMed     Abstract available


    March 2017
  14. FRIBERG G, Reese D
    Blinatumomab (Blincyto(R)); lessons learned from the bispecific t-cell engager (BiTE(R)) in acute lymphocytic leukemia (ALL).
    Ann Oncol. 2017 Mar 31. doi: 10.1093.
    PubMed     Abstract available


  15. VOSO MT, Leone G, Piciocchi A, Fianchi L, et al
    in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study.
    Ann Oncol. 2017 Mar 29. doi: 10.1093.
    PubMed     Abstract available


  16. BOLIS M, Garattini E, Paroni G, Zanetti A, et al
    Network-guided modeling allows tumor-type independent prediction of sensitivity to all-trans-retinoic acid.
    Ann Oncol. 2017;28:611-621.
    PubMed     Abstract available


    February 2017
  17. INABA H, Pei D, Wolf J, Howard SC, et al
    Infection-related complications during treatment for childhood acute lymphoblastic leukemia.
    Ann Oncol. 2017;28:386-392.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: